Literature DB >> 15358114

Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.

Ning Xu1, Peter Nilsson-Ehle, Maria Hurtig, Bo Ahrén.   

Abstract

It was previously shown that circulating levels of leptin and apolipoprotein M (apoM) correlate to each other. In this study, we examined whether plasma leptin and leptin-receptors are of importance for apoM expression in vivo. It was found that in both liver and kidney, expression of apoM was significantly lower in leptin deficient ob/ob mice and in leptin-receptor deficient db/db mice than in control mice. Furthermore, leptin administration (0.5 or 1.5 microg/g body weight) significantly increased plasma apoM levels and apoM mRNA levels in liver and in kidney in ob/ob mice. We conclude that both leptin and leptin-receptor are essential for the apoM expression, indicating that leptin is physiologically regulating apoM synthesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358114     DOI: 10.1016/j.bbrc.2004.06.180

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Proteomic analysis of vitreal exosomes in patients with proliferative diabetic retinopathy.

Authors:  Jiawei Wang; Zhenzhen Wang; Ying Zhang; Jianqiao Li
Journal:  Eye (Lond)       Date:  2022-10-17       Impact factor: 4.456

2.  Expression and localization of apolipoprotein M in human colorectal tissues.

Authors:  Guanghua Luo; Xiaoying Zhang; Qinfeng Mu; Lujun Chen; Lu Zheng; Jiang Wei; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2010-09-16       Impact factor: 3.876

3.  Molecular characterization, expression profile and association analysis with fat deposition traits of the porcine APOM gene.

Authors:  Gang Pan; Yayuan Fu; Bo Zuo; Zhuqing Ren; Dequan Xu; Minggang Lei; Rong Zheng; Yuan-Zhu Xiong
Journal:  Mol Biol Rep       Date:  2009-03-27       Impact factor: 2.316

Review 4.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Apolipoprotein M.

Authors:  Guanghua Luo; Xiaoying Zhang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2004-10-04       Impact factor: 3.876

6.  Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.

Authors:  Guanghua Luo; Yuehua Feng; Jun Zhang; Qinfeng Mu; Yuanping Shi; Li Qin; Lu Zheng; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Ning Xu
Journal:  Int J Med Sci       Date:  2014-07-29       Impact factor: 3.738

Review 7.  Apolipoprotein M-A Marker or an Active Player in Type II Diabetes?

Authors:  Christina Christoffersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

8.  Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.

Authors:  Ye Yi-zhou; Cao Bing; Li Ming-qiu; Wang Wei; Wang Ru-xing; Rui Jun; Wei Liu-yan; Jing Zhao-hui; Ji Yong; Jiao Guo qing; Zou Jian
Journal:  Lipids Health Dis       Date:  2012-12-05       Impact factor: 3.876

9.  Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.

Authors:  Jingting Jiang; Xiaoying Zhang; Changping Wu; Xihu Qin; Guanghua Luo; Haifeng Deng; Minyang Lu; Bin Xu; Min Li; Mei Ji; Ning Xu
Journal:  Lipids Health Dis       Date:  2008-07-24       Impact factor: 3.876

10.  Decreased activities of apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases.

Authors:  Lu Zheng; Guanghua Luo; Jun Zhang; Qinfeng Mu; Yuanping Shi; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Ning Xu
Journal:  Int J Med Sci       Date:  2014-02-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.